The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial.
 
Abhishek Tripathi
Honoraria - Cardinal Health; Targeted Oncology; Urology times
Consulting or Advisory Role - AADi; Deka Biosciences; EMD Serono; Exelixis; Exelixis; Foundation Medicine; Genzyme; Pfizer; Seagen; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Research Funding - Aravive (Inst); Bayer (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst); Exact Sciences (Inst); Exelixis (Inst); Pfizer (Inst); WindMIL (Inst)
 
Catherine Tangen
No Relationships to Disclose
 
Xiaochen Li
No Relationships to Disclose
 
Maria S. Tretiakova
No Relationships to Disclose
 
Peter Humphrey
Consulting or Advisory Role - Johnson & Johnson/Janssen
 
Adebowale Adeniran
No Relationships to Disclose
 
Pedro C. Barata
Honoraria - UroToday
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - AstraZeneca; Bayer (Inst); Caris Life Sciences (Inst); Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Merck (Inst); Pfizer (Inst)
 
Shuchi Gulati
Consulting or Advisory Role - AVEO; EMD Serono; Puma Biotechnology
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending for: "Diagnostic tools for prediction of survival and responsiveness to treatments.” US17327100.
Travel, Accommodations, Expenses - Conquer Cancer Foundation
 
Cristiane Decat Bergerot
No Relationships to Disclose
 
Deepak K Pruthi
No Relationships to Disclose
 
Ian Thompson
Leadership - H-E-B (grocery store chain)
Consulting or Advisory Role - Magforce
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Primo N Lara
Research Funding - Janssen Biotech (Inst); Taiho Pharmaceutical (Inst)
 
Sumanta Kumar Pal
Travel, Accommodations, Expenses - crispr therapeutics; Roche
 
Brian M. Shuch
Honoraria - Exelixis
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Histosonics; Johnson & Johnson/Janssen; Merck; Veracyte